What's new? Log in Free sign up

GeneThera (GTHR)

Company Profile

Company profile

Ticker

GTHR

Exchange

Website

www.genethera.net

CEO

Dr. Antonio Milici M.D., Ph.D.

Incorporated

Location

Fiscal year end

Sector

Health Technology > Biotechnology

Industry (SIC)

Biological Products, (No Diagnostic Substances)

Biomotion Sciences Ordinary Shares • Amgen • American National • Gilead Sciences • Biogen • Qiagen • Moderna • Bio-Techne • Acorda Therapeutics • BioNTech SE ...

Former names

[object Object]

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

IRS number

660622463

GTHR stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Notice of late annual filing

Letter from SEC

Annual report (amended)

31 Jan 23

Letter from SEC

Quarterly report

14 Nov 22

Quarterly report

18 Aug 22

Notice of late quarterly filing

Quarterly report

18 May 22

Notice of late quarterly filing

14 Apr 22

Latest ownership filings

No filings

Financial summary

Financial statements Chart GTHR financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from GeneThera earnings reports.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.